Used as a linker in antibody-drug conjugates (ADCs) to connect cytotoxic agents to monoclonal antibodies. Provides stable attachment during circulation while allowing controlled release of the drug inside target cells. Its design helps improve the therapeutic index by minimizing premature drug release and reducing off-target toxicity. Commonly paired with potent payloads in cancer therapies for enhanced efficacy and specificity.